In January 1980, a national external quality-control survey was organized to evaluate assays for triiodothyronine (T3) and thyroxin (T4). Currently, about 150 laboratories are involved. Each participanthas received and assayed 100 quality-control samples during four periods of about six monthseach. The average analyticalperformanceachieved by the participants in each six-month period was estimated by computing the average between-laboratory agreement (CVT), the overall average bias, and the average laboratory imprecision. During the 2.5 years of the survey, analytical performance has improved for both assays (CVT decreased from 17.0 to 15.7% for T3 and from 13.1 to 12.7% for T4.
(mean kitbias and kit imprecisionfor the nine kitsmostused by participants)showedthat the analyticalreliabilityof the T4 assay is generally better than that observed for T3, mainly because of the larger systematic differences among T3 kits.
Interlaboratory surveys,
widely used in clinical chemistry, have been extended to radioimmunoassay procedures in the last few years (1) (2) (3) . The major goal of external qualitycontrol surveys (EQCS)' is to improve the reliability of analyses done by the participating laboratories. By comparing their own performance with that of other laboratories and assessing the periodic EQCS reports, laboratories obtain useful information on the analytical reliability of a method or a kit. Update of the analytical performances of various kits, which is easily generated from the large amount of data collected during the interlaboratory survey, is a major tool for improving the quality of the assays for which they are used. The laboratories gain some quantitative basis for choosing among the available kits, and kit manufacturers are prompted to provide more reliable products.
Starting in January 1980, we organized a national EQCS for assays forT3 and T4 in which more than 150 laboratories are now involved (4, 5)2 During the first two-and-a-half years of the survey 100 samples have been sent to each participant, in 22 monthly dispatches.
From the results we have prepared monthly reports summarizing the statistics associated with each sample and four end-of-period reports containing estimates of the mean bias and imprecision achieved by each laboratory. Here we report a comparison of the analytical reliability achieved by the participants during the four periods of the EQCS, and evaluate the performances of the T3 and T4 kits the laboratories used in the fourth six-month period. 
Materials and Methods

Outline of the Scheme
Every month, each participating laboratory receives three to six samples of human serum (nonreactive for hepatitis B surface antigen), pooled from the excess after routine analysis forT3 and T4. Such pooled serum is filtered through 0.45-m pore-size filters (catalog designation HA; Millipore Corp., Bedford, MA), then is mixed with 10 mmol of sodium azide per liter, as preservative. EQCS samples are sent by mail, at room temperature. The laboratories are instructed to measure T3 and T4 in the samples by their routine procedures and to return the results thus obtained together with the name of the method (or kit) they used. Results are computer processed and a monthly report is printed containmg mean, median, SD, CV, and range-both for all results and for results subdivided according to the method or kitand sent back to each participant (5). All data accumulated during a six-month period are used to prepare an end-ofperiod report containing data on bias and imprecision of each participating laboratory; a plot of imprecision-bias is also included, to facilitate evaluation of each laboratory's performance (4, 6).
Data Analysis
From all results reported to the survey, the following 
Laboratory imprecision:
The mean imprecision estimated from results reported by the laboratory for unidentified replicate samples. A CV was computed from results of EQCS samples prepared from the same pool and assayed by the laboratory on two or more occasions during the sixmonth period; the mean imprecision was obtained by pooling the CVs for different replicate pools.3 3 example, if a laboratory displayed an imprecision CV, for the pool 1 assayed n, times and an imprecision CV2 for the pool 2 assayed n2 times, the mean laboratory imprecision CV was comput- 
Imprecision-bias
plot: This is a plot illustrating the laboratory imprecision and the laboratory bias achieved by each participant during the considered period. The distance from the origin on this plot, which is numerically equal to V(lab. imprecision)' + (lab. bias)z, is referred as "analytical reliability," and it corresponds to the percent deviation from the target value attributable to both random and systematic errors.
average between-laboratoty agreement: The pooled between-laboratory CV for all the EQCS samples mailed out in the considered period, CVT, is computed as: CVT= where CV is the coefficient of variation computed from results of all laboratories for the jth-EQCS samples. When the values for CV, were derived from different numbers of results, a weighted mean was computed bsing a formula analogous to that reported in footnote 3. CVT reflects both the laboratory imprecisions and the systematic differences among_laboratories.
BIAS%,
average bias: This is the root mean square of all the laboratory biases, computed as: BIAS = IA reflects systematic differences among laboratories mainly deriving from the use of different methods/kits.
CVL%, average imprecision:
This is the median of all the laboratory imprecisions. CVL accounts for the dispersion of the results of the laboratories in respect to their own means.
Kit bias: This is the mean of the percent deviations from the consensus mean of all the results reported by the users of the considered kit.
Kit imprecision:
This is the pooled CV computed from all results reported by the users of the considered kit for unidentified replicate EQCS samples sent in different dispatches.
In the computation of both the laboratory bias and the kit bias, the consensus mean was taken as the target value, because no authoritative reference method has as yet been developed for these assays. The validity of the consensus mean was checked by sending to the participants nine EQCS samples prepared from sera stripped of analyte and then supplemented with spectrophotometrically measured amounts of T3 and T4 (purchased from Henning, Berlin, F.R.G.) (7) . The consensus means found for these samples were very close to the expected values [mean recovery 101.3% (SD 4.3%) for T3 and 101.8% (SD 5.2%) for T4].
Results and Comments
The results reported here were those obtained on 100 EQCS samples sent during the period January 1980-June 1982 in 22 monthly dispatches. Four end-of-period reports were compiled during this period. The concentration of the EQCS samples ranged from 60 to 450 ng/L for T3 and from 20 to 170 /L for T4; the between-laboratory agreement for both assays was found to be approximately independent of concentration except for the low-concentration samples (<90 ng/L for T3, <40 p.g/L for T4), for which the betweenlaboratory CVs were higher (5). Results on these latter samples were therefore excluded from the computations. The number of participant laboratories and of EQCS samples in each of the four six-month periods are reported in Table 1 
(8) reported
data from which a between-laboratory agreement of 12.9% can be derived for a sample containing T4 in a concentration of 101 itg/L. During the two-and-a-half years of the EQCS, the average laboratory peformance appears to improve slightly for T4 and more appreciably for T3. The data in Table 1 indicate that, as far as assay fbr T3 is concerned, there was both an improvement in CVL and a decrease in BIAS. ForT4 assay, the essential improvement was a decrease in the average bias. The statistics obtained only for the subgroup-those participating in all the last three periods-show a similar behavior. Comparison of the imprecision-bias plots computed from the results for different periods is another approach to making evident the possible changes in average analytical performances of the participant laboratories. Figures 1 and  2 show, for T3 and T4, the imprecision-bias plots of the second and the fourth six-month periods for the same laboratories that participated in all the latter three periods. It can be seen that, on the average, these data are closer to the origin on the plot for the fourth six-month period. This corresponds to an improved analytical reliability. In fact, the percentage of laboratories assaying T4 with a reliability better than 12% is increased from 48 to 61%, and for T3 assay the percentage of laboratories displaying a poor reliability (>24%) is decreased from 18 to 5%. Figure 3 shows data on bias and imprecision forT3 and T4 during the fourth six-month period for the nine kits most used by participants (from six to 27 laboratories), to- seem to be the only means by which one can reliably and quantitatively evaluate the relative performance of a radioimmunoassay.
The average performance derived from EQCS results is useful to the respective participant laboratories as a reference point against which to compare their own performance.
Participation in an EQCS must not be considered as a substitute of the internal quality-control procedures carried out within each laboratory, because such procedures allow ±he daily evaluation of reliability.
The results of EQCS make it possible to inter-compare performances of different assays (in this paper we compared assay for T3 with assay for T4) and to monitor possible trends in their average performances. The data reported here demonstrate an improvement in assays for T3 and T4 during the last EQCS period. Although this change is a relatively small one, we conclude that the average performances of these assays is good in comparison with that attained by other radioimmunoassays.
Possibly this improvement can be partly ascribed to participation in the EQCS.
Another remarkable feature of the EQCS is to provide some basis for an evaluation of the available methods/kits. In fact, almost all laboratories now use kits for radioimmunoassays, and these are to be selected on the basis of analytical reliability rather than their practicability only. On the other hand, the single user can not easily perform, within his own laboratory, an experimental evaluation of the ever-increasing number of such commercially available This analysis points out that, on average, the reliability of the T4 kits is better than that of the T3 kits. In fact, four T4 kits exhibit a reliability of about 10% or better, while no kit does this well. The relatively poorer performances of the T3 kits in comparision with T4 kits seem ascribable more to the presence of larger biases than to poorer precision. The four kits in which the boundlfree separation is carried out by the use of antibody-coated tubes (BDI, CIA, DPC1, SPA, see legend to Figure 3 ) exhibit performances as discrepant as those found for kits based on different separation techniques. This suggests that analytical reliability does not directly reflect different methodological approaches but rather it depends on the technology of kit production and its control.
Discussion
These data confIrm the usefulness of setting up EQCS and of continuing them for long periods. Interlaboratory surveys kits. Therefore EQCS reports represent a valuable aid, because evaluation of kit performance is continuously updated and obtained from a large number of results produced in different laboratories. Such evaluations also represent a useful source of information and a stimulus for kit manufacturers to improve the reliability of their products.
